businesspress24.com - Selway Capital Acquisition Corporation Announces Final Results of Tender Offer for Series B Shares
 

Selway Capital Acquisition Corporation Announces Final Results of Tender Offer for Series B Shares

ID: 1254705

(firmenpresse) - NEW YORK, NY -- (Marketwired) -- 08/14/13 -- Selway Capital Acquisition Corporation (OTCQB: SWCB) (OTCQB: SWCAL) ("Selway") today announced that its previously announced tender offer (the "Offer") to purchase all of its outstanding Series B Shares of common stock, par value $0.0001 per share (the "Series B Shares"), at a price of $10.30 per share in cash, without interest, expired at 5:00 p.m., United States Eastern Time on the evening of Tuesday, August 13, 2013. Based on information provided by American Stock Transfer & Trust Company, LLC (the "Depositary"), pursuant to the terms of the Offer, 839,765 Shares were tendered for an aggregate purchase price of $8,649,579.50. The Company has accepted for redemption all of the Shares validly tendered and not withdrawn.



Following the consummation of Selway's acquisition of Healthcare Corporation of America on April 10, 2013, Selway operates its business through Healthcare Corporation of America. Healthcare Corporation of America is a rapidly growing pharmacy benefit manager, or PBM. Its mission is to reduce prescription drug costs for clients while improving the quality of drug care. It administers prescription drug benefit programs for employers who contract with it in order to provide this component of healthcare benefits to their employees. A growing customer base includes commercial clients of various sizes and industries, business associations and trade groups, local government entities, labor unions, charitable and non-profit organizations, and third-party administrators of self-insured benefit plans. The company operates in the marketplace under the name of its subsidiary, Prescription Corporation of America, or PCA.








Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  Xylitol Canada Provides Update on Its Commercialization Efforts
Cadus Reports Second Quarter 2013 Results
Bereitgestellt von Benutzer: Marketwired
Datum: 14.08.2013 - 08:39 Uhr
Sprache: Deutsch
News-ID 1254705
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

NEW YORK, NY


Phone:

Kategorie:

Drugs


Anmerkungen:


Diese Pressemitteilung wurde bisher 126 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Selway Capital Acquisition Corporation Announces Final Results of Tender Offer for Series B Shares
"
steht unter der journalistisch-redaktionellen Verantwortung von

Selway Capital Acquisition Corp (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Selway Capital Acquisition Corp



 

Who is online

All members: 10 564
Register today: 1
Register yesterday: 0
Members online: 0
Guests online: 101


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.